BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer and healthcare medical devices announced today that its Executive Vice President, Dr. Deepak Kotak has been invited to present BioElectronics' innovative chronic pain therapy at the OTC Pharma Asia Conference, http://www.otcpharmaasia.com/ on Tuesday, March 3, 2015 in Singapore.
Dr. Kotak, an anesthesiologist, talk "ActiPatch® Pain Therapy - Changing the Paradigm of OTC Chronic Pain" describes the science and how this new OTC drug-free therapy is transforming pain management and bringing "life-changing relief" to chronic pain sufferers.
"ActiPatch provides effective local pain treatment reducing the need for systemic therapies such as NSAID's and opioids, and reduces the risk of side-effects and adverse events that are a burden to the chronic pain population," Dr. Kotak said, "Our customers are reporting superior relief to most analgesics for conditions like fibromyalgia, back pain and arthritis." Dr. Kotak will also share his vision for BioElectronics technology to address additional health care issues.
A Fellow of the Royal College of Anesthesiologists (UK), Dr. Kotak is responsible for medical affairs, clinical research and new product development activities at BioElectronics Corporation a leading manufacturer of drug-free analgesic devices.
Prior to joining BioElectronics, Dr. Kotak was Chief Medical Officer of TraumaTec, a Houston medical device company, as well as a consultant to the Boss Group and Blackstone Valley Group, two private equity firms. Dr. Kotak has a broad medical background and health care experience having practiced as a specialist in intensive care medicine, anesthesia and trauma in a London teaching hospital. Dr. Kotak holds degrees in medicine from Oxford University and the University of London.
Vaccines targeting chronic diseases show promise in combatting age-related conditions